Anthropic's preparations for a potential 2026 initial public offering, including engagement of Wilson Sonsini and rejection of investor offers topping $800 billion valuation, drive the 92% market-implied "No" probability on acquisition before 2027, reflecting trader consensus on the AI lab's independence. Surging revenue—tripled to a $30 billion run-rate, with 2026 forecasts at $18 billion and profitability by 2027—stems from Claude large language model enterprise adoption outpacing OpenAI timelines, enabling self-sustainability amid competitive positioning with backers Amazon and Google. Recent moves like acquiring Coefficient Bio for $400 million and expanding London operations to 800 staff reinforce buy-side aggression over vulnerability. Upcoming IPO roadshows could cement odds, though regulatory pressures or compute bottlenecks might prompt strategic realignment.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$14,758 ปริมาณ
$14,758 ปริมาณ
$14,758 ปริมาณ
$14,758 ปริมาณ
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Nov 12, 2025, 5:14 PM ET
Resolver
0x65070BE91...Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Anthropic's preparations for a potential 2026 initial public offering, including engagement of Wilson Sonsini and rejection of investor offers topping $800 billion valuation, drive the 92% market-implied "No" probability on acquisition before 2027, reflecting trader consensus on the AI lab's independence. Surging revenue—tripled to a $30 billion run-rate, with 2026 forecasts at $18 billion and profitability by 2027—stems from Claude large language model enterprise adoption outpacing OpenAI timelines, enabling self-sustainability amid competitive positioning with backers Amazon and Google. Recent moves like acquiring Coefficient Bio for $400 million and expanding London operations to 800 staff reinforce buy-side aggression over vulnerability. Upcoming IPO roadshows could cement odds, though regulatory pressures or compute bottlenecks might prompt strategic realignment.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย